Israel Englander Forte Biosciences, Inc. Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$0.98 - $1.11 $40,782 - $46,192
-41,615 Reduced 42.16%
57,102 $59,000
Q1 2023

May 15, 2023
BUY
$0.98 - $1.06 $30,492 - $32,981
31,115 Added 46.03%
98,717 $100,000
Q4 2022

Feb 14, 2023
SELL
$0.96 - $28.0 $60,952 - $1.78 Million
-63,492 Reduced 48.43%
67,602 $68,000
Q3 2022

Nov 14, 2022
BUY
$1.06 - $27.75 $76,422 - $2 Million
72,097 Added 122.2%
131,094 $140,000

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0
View Full List

About Forte Biosciences, Inc.

FBRX Quotes by TradingView
  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $371M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email